Form 4: Maravai Lifesciences Holdings CFO Reports Stock Transaction
Insider Transaction (Form 4)
Rajesh Asarpota, Chief Financial Officer of Maravai Lifesciences Holdings, Inc., reported a transaction in 5,465 shares of common stock on July 30, 2026.
Summary
- Tax/exercise-price withholding: disposed of 5,465 Class A Common Stock at $6.59 ($36,014) on July 30, 2026; holds 428,951 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Rajesh Asarpota — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Tax/exercise-price withholding | Class A Common Stock | 5,465 | $7 | $36.0K | 428,951 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Tax/exercise-price withholding (5,465 shares) |
Keywords
insider transaction, Form 4, MRVI, MARAVAI LIFESCIENCES HOLDINGS, INC., neutral, Rajesh Asarpota
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.